Cyclines and acne: Pay attention to adverse drug reactions! A recent literature review;Cyclines et acné: Attention aux effets indésirables! Aspects récents de la littérature

Revue de Medecine Interne

Volumn 24, Issue 5, 2003, Pages 305-316

  Grasset, L ^a   Guy, C ^a   Ollagnier, M ^a  

^a SERVICE DE NEUROLOGIE   (France)

Author keywords

Adverse dug reactions; Auto immunity; Hypersensitivity syndrome; Pseudotumor cerebri; Tetracyclines

Indexed keywords

CYCLINE; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

ACNE; ALOPECIA; ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BRAIN PSEUDOTUMOR; CHRONIC HEPATITIS; DATA ANALYSIS; DYSPNEA; ESOPHAGUS ULCER; FACE EDEMA; FATIGUE; FEVER; HEPATOSPLENOMEGALY; HUMAN; HYPEREOSINOPHILIA; HYPERSENSITIVITY; HYPOTENSION; JAUNDICE; KIDNEY DISEASE; LEUKOCYTOSIS; LIVEDO RETICULARIS; LONG TERM CARE; LUNG DISEASE; LUPUS ERYTHEMATOSUS; LYMPHADENOPATHY; MALAISE; MYALGIA; NAIL PIGMENTATION; NAUSEA; PHOTOSENSITIVITY DISORDER; PIGMENT DISORDER; POLYARTERITIS NODOSA; PRURITUS; RASH; RESPIRATORY DISTRESS; REVIEW; SERUM SICKNESS; SIDE EFFECT; SKIN DISEASE; SKIN PIGMENTATION; SPLENOMEGALY; URTICARIA; VASCULITIS; VOMITING;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; AUTOIMMUNE DISEASES; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHOTOSENSITIVITY DISORDERS; PSEUDOTUMOR CEREBRI; SERUM SICKNESS; SKIN PIGMENTATION; TETRACYCLINES; TIME FACTORS; VASCULITIS;

EID: 0037528041     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(02)00017-6     Document Type: Review

References (76)

1. e ed. New-York: Mc Graw Hill; 2001.
2. Akin E, Miller LC, Tucker LB. Minocycline-induced lupus in adolescents. Pediatrics 1998;101:926-8.
3. Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and auto-immune hepatitis. Semin Arthritis Rheum 1998;28:187-92.
4. Bhat G, Jordan J, Sokalski S, Bajaj V, Marshall R, Berkelhammer C. Minocycline-induced hepatitis with auto-immune features and neutropenia. J Clin Gastroenterol 1998;27:74-5.
5. Bonnotte B, Gresset AC, Chauffert B, Courtois JM, Martin F, Collet E, et al. Symptômes évocateurs de maladie de système chez des patientes prenant du chlorhydrate de minocycline. Presse Méd 1999; 28:1105-8.
6. Christodoulou CS, Emmanuel P, Ray RA, Good RA, Schnapf BM, Cawkwell GD. Respiratory distress due to minocycline-induced pulmonary lupus. Chest 1999;115:1471-3.
7. Crosson J, Stillman MT. Minocycline-related lupus erythematosus with associated liver disease. J Am Acad Dermatol 1997;36:867-8.
8. Dadamessi I, Leduc I, Duché A, Tiev K, Barbieux D, Sevestre H, Andréjak M, Ducroix JP. Auto-immune hepatitis and lupus syndrome associated with minocycline. Rev Med Interne 1999;20:930-3.
9. Dunphy J, Rands A, McHugh NJ. Anti-myeloperoxidase antibodies in minocycline-induced lupus syndrome. Br J Rheumatol 1997; 36(Suppl. 1):5.
10. Elkayam O, Levartovsky D, Brautbar C, Yaron M, Burke M, Vardinon N, Caspi D. Clinical and immunological study of 7 patients with minocycline-induced autoimmune phenomena. Am J Med 1998;105: 484-7.
11. Farver DK. Minocycline-induced lupus. Ann Pharmacother 1997;31: 1160-3.
12. Golstein PE, Deviere J, Cremer M. Acute hepatitis and drug-related lupus induced by minocycline treatment. Am J Gastroenterol 1997;92: 143-6.
13. Gordon MM, Porter D. Minocycline induced lupus: case series in the west of Scotland. J Rheumatol 2001;28:1004-6.
14. Herzog D, Hajoui O, Russo P, Alvarez F. Study of immune reactivity of minocycline-induced chronic active hepatitis. Dig Dis Sci 1997;42: 1100-3.
15. Knights SE, Leandro MJ, Khamashta MA, Hughes GR. Minocyclineinduced arthritis. Clin Exp Rheumatol 1998;16:587-90.
16. Konaté A, Wojtusciszyn A, Ceballos P, Riviére S, Le Quellec A. Lupus systémique et myosite lymphocytaire induits par la minocycline. Rev Med Interne 2001;22(Suppl 4):489s.
17. Leitch DN, Haslock DI. Psoriatic arthritis and minocycline induced auto-antibodies. Clin Rheumatol 1997;16:317-8.
18. Matteson EL, Johnson BW, Maher JD. Arthralgias, myalgias, and auto-immune hepatitis with minocycline therapy. J Rheumatol 1998; 25:1653-4.
19. Nietsch HH, Libman BS, Pansze TW, Eicher JN, Reeves JR, Krawitt EL. Minocycline-induced hepatitis. Am J Gastroenterol 2000; 95:2993-5.
20. Pavese P, Sarrot-Reynauld F, Bonadona A, Massot C. Immunoallergic reaction with hepatitis induced by minocycline. Ann Med Interne 1998;149:521-3.
21. Piette AM, Ramanoelina J, Gepner P, Larroche C, Blétry O. Systemic reactions induced by minocycline treatment: a report of four patients and a review of the literature. Rev Med Interne 1999;20:869-74.
22. Pohle T, Menzel J, Domschke W. Minocycline and fulminant hepatic failure necessitating liver transplantation. Am J Gastroenterol 2000; 95:560-1.
23. Pointud P. Minocycline related lupus. J Rheumatol 1997;24:1951-2.
24. Somech R, Arav-Boger R, Assia A, Spirer Z, Jurgenson U. Complications of minocycline therapy for acne vulgaris: case reports and review of the literature. Pediatr Dermatol 1999;16:469-72.
25. Sorbi D, Thistle JL. Minocycline, an unusual cause of drug-induced lupus and auto-immune hepatitis. Am J Gastroenterol 1997;92:1732.
26. Teitelbaum JE, Perez-Atayde AR, Cohen M, Bousvaros A, Jonas MM. Minocycline-related auto-immune hepatitis: case series and literature review. Arch Pediatr Adolesc Med 1998;152:1132-6.
27. Tournigand C, Genereau T, Prudent M, Diemert MC, Herson S, Chosidow O. Minocycline-induced clinical and biological lupus-like disease. Lupus 1999;8:773-4.
28. Tubach F, Kaplan G, Berenbaum F. Highly positive dsDNA antibodies in minocycline-induced lupus. Clin Exp Rheumatol 1999;17:124-5.
29. Gisserot O, de Jaureguiberry JP, Cremades S, Laporte C, Jaubert D. Pseudopolymyositis possibly induced by minocycline. Presse Méd 2000;29:1703-4.
30. Colmegna I, Perandones CE, Chaves JG. Minocycline induced lupus and auto-immune hepatitis. J Rheumatol 2000;27:1567-8.
31. Schrodt BJ, Kulp-Shorten CL, Callen JP. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris. South Med J 1999;92:502-4.
32. Schrodt BJ, Callen JP. Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris. Pediatrics 1999;103:503-4.
33. Schaffer JV, Davidson DM, McNiff JM, Bolognia JL. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris. J Am Acad Dermatol 2001;44:198-206.
34. Bénéton N, Bocquet H, Cosnes A, Revuz J, Roujeau JC. Benefit-risk assessment of Bene therapies. Lancet 1997;349:1252.
35. Christe C, Ricou F, Stoller R, Vogt N. Minocycline-induced pericardial effusion. Ann Pharmacother 2000;34:875-7.
36. Clayton BD, Hichcock MG, Williford PM. Minocycline hypersensitivity with respiratory failure. Arch Dermatol 1999;135:139-40.
37. Colvin JH, Sheth AP. Minocycline hypersensitivity syndrome with hypotension mimicking septic shock. Pediatr Dermatol 2001;18: 295-8.
38. Kettaneh A, Fain O, Ziol M, Lejeune F, Eclache V, Biaggi A, et al. Granulomatose hépatique et médullaire avec cellules de Sézary circulantes au cours d'une réaction d'hypersensibilité à la minocycline. Rev Med Interne 1999;20(Suppl 6):693s.
39. Levy A, Mal H, Roué C, Crestani B, Fournier M, Pariente R. Pneumopathie à la minocycline. Presse Méd 1997;26:1671-2.
40. Lupton JR, Figueroa P, Tamjidi P, Berberian BJ, Sulica VI. An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction. Cutis 1999;64:91-6.
41. MacNeil M, Haase DA, Tremaine R, Marrie TJ. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. J Am Acad Dermatol 1997; 36:347-50.
42. de Paz S, Perez A, Gomez M, Trampal A, Dominguez Lazaro A. Severe hypersensitivity reaction to minocycline. Invest Allergol Clin Immunol 1999;9:403-4.
43. Raison-Peyron N, Dereure O, Meunier L, Guilhou JJ, Meynadier J. Pseudo-maladie sérique après prise de minocycline. Presse Méd 1998; 27:261-2.
44. Malakar S, Dhar S, Shah Malakar RS. Is serum sickness an uncommon adverse effect of minocycline treatment? Arch Dermatol 2001; 137:100-1.
45. Chiu AM, Chuenkongkaew WL, Cornblath WT, Trobe JD, Digre KB, Dotan SA, Musson KH, Eggenberger ER. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 1998;126:116-21.
46. Kingston H. Tetracyclines and benign intracranial hypertension - a headache rare but real, Media release (3 pages), 2001. Tetracyclines and benign intracranial hypertension - a headache rare but real, Media release (3 pages), 2001. Available from: URL: http: //www.medsafe.govt.nz.
47. Lewis PA, Kearney PJ. Pseudotumor cerebri induced by minocycline treatment for ache vulgaris. Acta Dermatol Venereol 1997;77:83.
48. Nagarajan L, Lam GC. Tetracycline-induced benign intracranial hypertension. J Paediatr Child Health 2000;36:82-3.
49. Quinn AG, Singer SB, Buncic JR. Pediatric tetracycline-induced pseudotumor cerebri. J AAPOS 1999;3:53-7.
50. Shiri J, Amichai B. Intracranial hypertension and minocycline. Ann Intern Med 1997;127:168.
51. Weese-Mayer DE, Yang RJ, Mayer JR, Zaparackas Z. Minocycline and pseudotumor cerebri: the well-known but well-kept secret. Pediatrics 2001;108:519-20.
52. Archer CB. Minocycline-induced skin and tissue pigmentation. Prescribers' J 1998;38:47-9.
53. Eisen D, Hakim MD. Minocycline-induced pigmentation, Incidence, prevention and management. Drug Safety 1998;18:431-40.
54. Ho NC, Levy H, Francomano CA, Elkayam O. Minocycline-induced generalized postinflammatory elastolysis. Am J Med 2000;109: 340-1.
55. Peyriere H, Hillaire-Buys D, Dereure O, Meunier L, Blayac JP. Muco-cutaneous pigmentation and photosensitization induced by minocycline hydrochloride. J Dermatol Treat 1999;10:105-12.
56. Morrow GL, Abbott RL. Minocycline-induced scleral, dental, and dermal pigmentation. Am J Ophthalmol 1998;125:396-7.
57. Patel K, Cheshire D, Vance A. Oral and systemic effects of prolonged minocycline therapy. Br Dent J 1998;185:560-2.
58. Tanzi EL, Hecker MS. Minocycline-induced hyperpigmentation of the tongue. Arch Fam Med 2000;9:687-8.
59. Eisen D. Minocycline-induced oral hyperpigmentation. Lancet 1997; 349:400.
60. Westbury LW, Najera A. Minocycline-induced intra-oral pharmacogenic pigmentation: case reports and review of the literature. J Periodontol 1997;68:84-91.
61. Fraunfelder FT, Randall JA. Minocycline-induced scleral pigmentation. Ophtalmology 1997;104:936-8.
62. Butt A, Statham BN. Minocycline-induced pigmentation of basal cell carcinomas. J Dermatol Treat 1998;9:39-40.
63. Tanaka N, Kawada A, Ohnishi Y, Hiruma M, Tajima S, Akiyama M, Ishibashi A. Photosensitivity due to doxycycline hydrochloride with an unusual flare. Contact Dermatitis 1997;37:93-4.
64. Isler M. Doxycycline-induced esophageal ulceration. Mil Med 2001; 166:203-22.
65. Bihorac A, Ozener C, Akoglu E, Kullu S. Tetracycline-induced acute interstitial nephritis as a cause of acute renal failure. Nephron 1999; 81:72-5.
66. Chetaille E, Delcenserie R, Yzet T, Decocq G, Biour M, Andrejak M. Imputabilité de la minocycline dans 2 observations de pancréatite aiguë. Gastroenterol Clin Biol 1998;22:555-6.
67. Nelva A, Mourier-Clavreul C, Jouglard J, Guy C, Ratrema M, Ollagnier M. An unexpected side-effect: striae distensae with minocyclin 3 cases. Thérapie 1999;54:273.
68. Biour M, Brion N. Le rapport bénéfices/risques des cyclines dans l'acné. La lettre du Pharmacologue 1999;13:140-7.
69. Recommandations et références médicales (ANDEM): Acné: traitement de l'acné par voie générale, indications, problèmes posés. Concours Med 1997;30:2233-7.
70. Masson C, Yakova M. Minocycline: Hyde ou Jekyl? Rev Med Interne 1999;20:859-62.
71. Hess EV. Minocycline and autoimmunity. Clin Exp Rheumatol 1998; 16:519-21.
72. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Arch Intern Med 1999;159: 493-7.
73. Gottlieb A. Safety of minocycline for acne. Lancet 1997;349:374.
74. Mac Hugh NJ. Minocycline-induced lupus and auto-immune phenomena. Lupus 1999;8:417-8.
75. Singer SJ, Piazza-Hepp TD, Girardi LS, Moledina NR. Lupuslike reaction associated with Minocycline. JAMA 1997;277:295-6.
76. Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol 2001; 137(1):69-73.